Amylyx Pharmaceuticals Inc(AMLX-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.49 | N/A | -2.84 | -1.50 |
| Number of Estimates | 2 | 0 | 3 | 3 |
| High Estimate | -0.46 | N/A | -2.18 | -1.01 |
| Low Estimate | -0.51 | N/A | -4.12 | -1.75 |
| Prior Year | 0.07 | -0.46 | 0.70 | -2.84 |
| Growth Rate Est. (year over year) | -800.00% | +217,273.91% | -505.71% | +47.18% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $-0.53 | $-0.73 | $-0.46 | $0.07 |
| Estimate | $-0.47 | $-0.38 | $0.24 | $0.20 |
| Difference | -0.06 | -0.35 | -0.70 | -0.13 |
| Surprise | -12.77% | -92.11% | -291.67% | -65.00% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
3.29
3 Mths Ago7
3.29
2 Mths Ago7
3.29
1 Mth Ago7
3.57
Current7
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 7 | 7 | 7 | 7 |
1 | 1 | 1 | 2 | |
| Holds | 6 | 6 | 6 | 5 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell